Klinisches Management bei Pruritus

Standard

Klinisches Management bei Pruritus. / Ständer, Sonja; Zeidler, Claudia; Magnolo, Nina; Raap, Ulrike; Mettang, Thomas; Kremer, Andreas E; Weisshaar, Elke; Augustin, Matthias.

in: J DTSCH DERMATOL GES, Jahrgang 13, Nr. 2, 02.2015, S. 101-116.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Ständer, S, Zeidler, C, Magnolo, N, Raap, U, Mettang, T, Kremer, AE, Weisshaar, E & Augustin, M 2015, 'Klinisches Management bei Pruritus', J DTSCH DERMATOL GES, Jg. 13, Nr. 2, S. 101-116. https://doi.org/10.1111/ddg.12522

APA

Ständer, S., Zeidler, C., Magnolo, N., Raap, U., Mettang, T., Kremer, A. E., Weisshaar, E., & Augustin, M. (2015). Klinisches Management bei Pruritus. J DTSCH DERMATOL GES, 13(2), 101-116. https://doi.org/10.1111/ddg.12522

Vancouver

Ständer S, Zeidler C, Magnolo N, Raap U, Mettang T, Kremer AE et al. Klinisches Management bei Pruritus. J DTSCH DERMATOL GES. 2015 Feb;13(2):101-116. https://doi.org/10.1111/ddg.12522

Bibtex

@article{b0ad37af546042d1bbc643441758199f,
title = "Klinisches Management bei Pruritus",
abstract = "The care of patients with chronic pruritus as a symptom of a wide variety of underlying diseases continues to confront dermatologists with diagnostic and therapeutic challenges. However, a structured history and a physical examination may already substantially help in narrowing down the number of potential differential diagnoses. Apart form reducing the intensity of pruritus, identification and appropriate treatment of the underlying disease are important needs of patients. If these goals doesn't lead to improvement of itch, current guidelines provide a number of topical and systemic therapies for symptomatic treatment. Various skin lesions (for example, xerosis caused by irritant substances, secondary scratch lesions) prompt patients to consult a dermatologist, but most cases require an interdisciplinary therapeutic approach to identify potential internal medicine, neurologic, or psychosomatic aspects. Although great strides have been made in basic research, specific therapies are still rare, and a precise knowledge of the legal framework for the implementation of guidelines (for example, off-label use) is essential. This CME article gives an overview of the causes of and treatment options for chronic pruritus and discusses both advances in basic research as well as progress in clinical knowledge.",
author = "Sonja St{\"a}nder and Claudia Zeidler and Nina Magnolo and Ulrike Raap and Thomas Mettang and Kremer, {Andreas E} and Elke Weisshaar and Matthias Augustin",
note = "{\textcopyright} 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.",
year = "2015",
month = feb,
doi = "10.1111/ddg.12522",
language = "Deutsch",
volume = "13",
pages = "101--116",
journal = "J DTSCH DERMATOL GES",
issn = "1610-0379",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Klinisches Management bei Pruritus

AU - Ständer, Sonja

AU - Zeidler, Claudia

AU - Magnolo, Nina

AU - Raap, Ulrike

AU - Mettang, Thomas

AU - Kremer, Andreas E

AU - Weisshaar, Elke

AU - Augustin, Matthias

N1 - © 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

PY - 2015/2

Y1 - 2015/2

N2 - The care of patients with chronic pruritus as a symptom of a wide variety of underlying diseases continues to confront dermatologists with diagnostic and therapeutic challenges. However, a structured history and a physical examination may already substantially help in narrowing down the number of potential differential diagnoses. Apart form reducing the intensity of pruritus, identification and appropriate treatment of the underlying disease are important needs of patients. If these goals doesn't lead to improvement of itch, current guidelines provide a number of topical and systemic therapies for symptomatic treatment. Various skin lesions (for example, xerosis caused by irritant substances, secondary scratch lesions) prompt patients to consult a dermatologist, but most cases require an interdisciplinary therapeutic approach to identify potential internal medicine, neurologic, or psychosomatic aspects. Although great strides have been made in basic research, specific therapies are still rare, and a precise knowledge of the legal framework for the implementation of guidelines (for example, off-label use) is essential. This CME article gives an overview of the causes of and treatment options for chronic pruritus and discusses both advances in basic research as well as progress in clinical knowledge.

AB - The care of patients with chronic pruritus as a symptom of a wide variety of underlying diseases continues to confront dermatologists with diagnostic and therapeutic challenges. However, a structured history and a physical examination may already substantially help in narrowing down the number of potential differential diagnoses. Apart form reducing the intensity of pruritus, identification and appropriate treatment of the underlying disease are important needs of patients. If these goals doesn't lead to improvement of itch, current guidelines provide a number of topical and systemic therapies for symptomatic treatment. Various skin lesions (for example, xerosis caused by irritant substances, secondary scratch lesions) prompt patients to consult a dermatologist, but most cases require an interdisciplinary therapeutic approach to identify potential internal medicine, neurologic, or psychosomatic aspects. Although great strides have been made in basic research, specific therapies are still rare, and a precise knowledge of the legal framework for the implementation of guidelines (for example, off-label use) is essential. This CME article gives an overview of the causes of and treatment options for chronic pruritus and discusses both advances in basic research as well as progress in clinical knowledge.

U2 - 10.1111/ddg.12522

DO - 10.1111/ddg.12522

M3 - SCORING: Zeitschriftenaufsatz

C2 - 25631127

VL - 13

SP - 101

EP - 116

JO - J DTSCH DERMATOL GES

JF - J DTSCH DERMATOL GES

SN - 1610-0379

IS - 2

ER -